SIRT5 regulates pancreatic β-cell proliferation and insulin secretion in type 2 diabetes.
In conclusion, the results of the present study indicate that SIRT5 may serve an important role in the pathogenesis of T2D, and may present a novel therapeutic target for the treatment of patients with T2D.
PMID: 30116390 [PubMed]
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Insulin | Pancreas | Study